A Study of SPY072 in Rheumatic Disease
Clinical trial NCT07148414 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07148414
- Sponsor
- Spyre Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-21
- Primary completion
- 2026-10-31
- Enrollment
- 285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.